OasisLMS

Upon completion of this activity, participants will be able to:

• Explain the mechanisms of action of current anticoagulant therapies, their impact on specific pathways of the coagulation cascade, and their potential to elevate the risk of serious bleeding events
• Identify and describe the role of novel coagulation pathways, such as factor XIa inhibition, in the development of safer and more effective anticoagulant therapies
• Assess the benefits and risks associated with emerging anticoagulant therapies, focusing on their potential to reduce bleeding complications while maintaining efficacy in thromboembolic event prevention
• Assess the potential of factor XI as a therapeutic target to reduce thrombotic risk while minimizing bleeding complications in patients with acute coronary syndromes